Clinical trials
Optic Nerve Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 3 |
| 2016 | 2 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 11 |
| Completed | 5 |
| Terminated | 5 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Duke University | 3 |
| MD Stem Cells | 2 |
| Stanford University | 2 |
| University of Miami | 2 |
| Astellas Pharma Global Development, Inc. | 1 |
| Bayer | 1 |
| Children's National Research Institute | 1 |
| Clene Nanomedicine | 1 |
| Dompé Farmaceutici S.p.A | 1 |
| Illinois Institute of Technology | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Optic Nerve Diseases | 25 |
| Glaucoma | 11 |
| Retinal Diseases | 9 |
| Optic Neuropathy, Ischemic | 6 |
| Macular Degeneration | 5 |
| Blindness | 3 |
| Eye Diseases | 3 |
| Optic Atrophy, Hereditary, Leber | 3 |
| Vision Disorders | 3 |
| Cone Dystrophy | 2 |
Trials
Showing 26 to 25 of 25. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.